dc.contributor.author | Durgun, Mustafa. | |
dc.contributor.author | Ceylan, Umit | |
dc.contributor.author | Yalcin, Serife Pinar | |
dc.contributor.author | Turkmen, Hasan | |
dc.contributor.author | Özdemir, Namık | |
dc.contributor.author | Koyuncu, Ismail | |
dc.date.accessioned | 2020-06-21T13:32:57Z | |
dc.date.available | 2020-06-21T13:32:57Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 0022-2860 | |
dc.identifier.issn | 1872-8014 | |
dc.identifier.uri | https://doi.org/10.1016/j.molstruc.2016.02.062 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/13293 | |
dc.description | Ozdemir, Namik/0000-0003-3371-9874; Durgun, Mustafa/0000-0003-3012-7582; ceylan, umit/0000-0002-1461-9889; ceylan, umit/0000-0003-2888-2378 | en_US |
dc.description | WOS: 000374073800011 | en_US |
dc.description.abstract | In present work, the sulfonamide compound, 3-chloro-N-(4-sulfamoylphenethyl)propanamide, has been synthesized and characterized by FT-IR, H-1-NMR, C-13-NMR, UV-vis and X-Ray single crystal determination. The compound crystallizes in the monoclinic space group P2(1)/c with a = 8.4493(4) angstrom, b = 17.5875(7) angstrom, c = 9.2593(4) angstrom and beta = 103.579(4)degrees, and Z = 4 in the unit cell. The molecular geometry from X-ray experiment in the ground state and vibrational frequencies, H-1 and C-13-NMR chemical shifts, absorption wavelengths have been calculated by using the Density Functional Theory (DFT) method with 6-311++G(d,p) basis set and compared with the experimental values. In addition, Molecular Electrostatic Potential (MEP), Natural Bond Orbital (NBO), Frontier Molecular Orbital (FMO) analysis, thermodynamic properties, dipole moments, and HOMO-LUMO energy were also computed. The calculated results show that the optimized geometry can well reproduce the crystal structure parameters, and the vibrational frequencies, H-1 and C-13-NMR chemical shifts, absorption wavelengths are in agreement with experimental values. Further, the synthesized compound was evaluated for in vitro cytotoxic activity against various tumour cells and normal cell line using MTT assay. The synthesized compound show the highest antiproliferative effect against ECC-1 tumour cells (IC50 = 0,167 mM), while the lowest cytotoxic activity against normal cell (HEK-293 and PNT1A) cell line (IC50 = 0.603 and 0.696 mM, respectively). (C) 2016 Elsevier B.V. All rights reserved. | en_US |
dc.description.sponsorship | Technological and Scientific Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [115Z681]; Harran University Scientific Research Project Coordinator (HUBAK) [1136, 12060] | en_US |
dc.description.sponsorship | This study supported by Harran University Scientific Research Project Coordinator (HUBAK-Project nos: 1136 and 12060) and by Technological and Scientific Research Council of Turkey (TUBITAK-Project no: 115Z681). The authors thank Harran University Chemistry Department and Central Laboratory for IR and NMR, respectively; Ondokuz Mayis University for XRD measurement of the title compound. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.isversionof | 10.1016/j.molstruc.2016.02.062 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | X-ray diffraction | en_US |
dc.subject | In vitro cytotoxicity study | en_US |
dc.subject | Quantum chemical calculations | en_US |
dc.subject | Sulfonamide | en_US |
dc.subject | Characterization | en_US |
dc.title | Synthesis, molecular structure, spectroscopic characterization, NBO, NLO and NPA analysis and in vitro cytotoxicity study of 3-chloro-N-(4-sulfamoylphenethyl)propanamide with experimental and computational study | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 1114 | en_US |
dc.identifier.startpage | 95 | en_US |
dc.identifier.endpage | 107 | en_US |
dc.relation.journal | Journal of Molecular Structure | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |